Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-10-28

Clinical Trial Update: An Observational Study to Assess Response to Tamoxifen in Breast Cancer Patients

View source ↗

Summary

An observational study evaluating how patients with estrogen receptor-positive breast cancer respond to tamoxifen.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tamoxifen (tamoxifen)

Snippet

Sponsor: Vlaamse Vereniging voor Obstetrie en Gynaecologie | Conditions: ER-positive Breast Cancer | Status: COMPLETED